| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDOB
|
aldolase B, fructose-bisphosphate
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMOT
|
angiomotin
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
AMY1A
|
amylase, alpha 1A (salivary)
|
|
AMY1B
|
amylase, alpha 1B (salivary)
|
|
AMY1C
|
amylase, alpha 1C (salivary)
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANKRD6
|
ankyrin repeat domain 6
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
AP1G2
|
adaptor-related protein complex 1, gamma 2 subunit
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP7
|
aquaporin 7
|
|
AR
|
androgen receptor
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASF1A
|
anti-silencing function 1A histone chaperone
|
|
ASF1B
|
anti-silencing function 1B histone chaperone
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP6V0B
|
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b
|
|
ATP6V0E1
|
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1
|
|
ATP6V1A
|
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRIP
|
ATR interacting protein
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIN1
|
bridging integrator 1
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BNIP3L
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTAF1
|
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C3
|
complement component 3
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CAT
|
catalase
|
|
CCAT2
|
colon cancer associated transcript 2 (non-protein coding)
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNC
|
cyclin C
|
|
CCNT1
|
cyclin T1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD69
|
CD69 molecule
|
|
CD9
|
CD9 molecule
|
|
CDC45
|
cell division cycle 45
|
|
CDC7
|
cell division cycle 7
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM16
|
carcinoembryonic antigen-related cell adhesion molecule 16
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CEP63
|
centrosomal protein 63kDa
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHAF1B
|
chromatin assembly factor 1, subunit B (p60)
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHGB
|
chromogranin B
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CIDEC
|
cell death-inducing DFFA-like effector c
|
|
CINP
|
cyclin-dependent kinase 2 interacting protein
|
|
CLIP2
|
CAP-GLY domain containing linker protein 2
|
|
CLU
|
clusterin
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL5A2
|
collagen, type V, alpha 2
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREBBP
|
CREB binding protein
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTC1
|
CTS telomere maintenance complex component 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB5R3
|
cytochrome b5 reductase 3
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DAXX
|
death-domain associated protein
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DMTF1
|
cyclin D binding myb-like transcription factor 1
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
DNAJC10
|
DnaJ (Hsp40) homolog, subfamily C, member 10
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha)
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DTD1
|
D-tyrosyl-tRNA deacylase 1
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EAF2
|
ELL associated factor 2
|
|
EDN1
|
endothelin 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4A3
|
eukaryotic translation initiation factor 4A3
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ETM2
|
essential tremor 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHL1
|
four and a half LIM domains 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXA1
|
forkhead box A1
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FYB
|
FYN binding protein
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GANC
|
glucosidase, alpha; neutral C
|
|
GAS1
|
growth arrest-specific 1
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GCG
|
glucagon
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJD2
|
gap junction protein, delta 2, 36kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSR
|
glutathione reductase
|
|
GTF2I
|
general transcription factor IIi
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
|
HBB
|
hemoglobin, beta
|
|
HDAC4
|
histone deacetylase 4
|
|
HEPACAM
|
hepatic and glial cell adhesion molecule
|
|
HERC1
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPAB
|
heterogeneous nuclear ribonucleoprotein A/B
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IER3
|
immediate early response 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IL10
|
interleukin 10
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSR
|
insulin receptor
|
|
IRF1
|
interferon regulatory factor 1
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ISM1
|
isthmin 1, angiogenesis inhibitor
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LCT
|
lactase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIPC
|
lipase, hepatic
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LIPG
|
lipase, endothelial
|
|
LPL
|
lipoprotein lipase
|
|
MAOA
|
monoamine oxidase A
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDFI
|
MyoD family inhibitor
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MLYCD
|
malonyl-CoA decarboxylase
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSTN
|
myostatin
|
|
MT2A
|
metallothionein 2A
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYBPH
|
myosin binding protein H
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
NAA15
|
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCSTN
|
nicastrin
|
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NKAIN2
|
Na+/K+ transporting ATPase interacting 2
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOM1
|
nucleolar protein with MIF4G domain 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX1
|
NADPH oxidase 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
OBFC1
|
oligonucleotide/oligosaccharide-binding fold containing 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OS9
|
osteosarcoma amplified 9, endoplasmic reticulum lectin
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX8
|
paired box 8
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PER1
|
period circadian clock 1
|
|
PES1
|
pescadillo ribosomal biogenesis factor 1
|
|
PF4
|
platelet factor 4
|
|
PI4KB
|
phosphatidylinositol 4-kinase, catalytic, beta
|
|
PIAS2
|
protein inhibitor of activated STAT, 2
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLIN3
|
perilipin 3
|
|
PLK1
|
polo-like kinase 1
|
|
PML
|
promyelocytic leukemia
|
|
PNKP
|
polynucleotide kinase 3'-phosphatase
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLI
|
polymerase (DNA directed) iota
|
|
PON1
|
paraoxonase 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPP3R1
|
protein phosphatase 3, regulatory subunit B, alpha
|
|
PRICKLE1
|
prickle homolog 1 (Drosophila)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
RAB11FIP1
|
RAB11 family interacting protein 1 (class I)
|
|
RAB26
|
RAB26, member RAS oncogene family
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAI1
|
retinoic acid induced 1
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RB1
|
retinoblastoma 1
|
|
RBM8A
|
RNA binding motif protein 8A
|
|
RECQL5
|
RecQ protein-like 5
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RETN
|
resistin
|
|
RHOA
|
ras homolog family member A
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPL5
|
ribosomal protein L5
|
|
RPS19
|
ribosomal protein S19
|
|
RSF1
|
remodeling and spacing factor 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD7
|
SMAD family member 7
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOST
|
sclerostin
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SP1
|
Sp1 transcription factor
|
|
SPATA18
|
spermatogenesis associated 18
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative)
|
|
SPRR3
|
small proline-rich protein 3
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STIM1
|
stromal interaction molecule 1
|
|
SUN1
|
Sad1 and UNC84 domain containing 1
|
|
SUN2
|
Sad1 and UNC84 domain containing 2
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
TAAR1
|
trace amine associated receptor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBP
|
TATA box binding protein
|
|
TECTA
|
tectorin alpha
|
|
TECTB
|
tectorin beta
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TEN1
|
TEN1 CST complex subunit
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFEB
|
transcription factor EB
|
|
TFF2
|
trefoil factor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TTR
|
transthyretin
|
|
UBA7
|
ubiquitin-like modifier activating enzyme 7
|
|
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2
|
|
UBIAD1
|
UbiA prenyltransferase domain containing 1
|
|
VAC14
|
Vac14 homolog (S. cerevisiae)
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIP
|
vasoactive intestinal peptide
|
|
VWF
|
von Willebrand factor
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WDR77
|
WD repeat domain 77
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
YAP1
|
Yes-associated protein 1
|
|
YY1AP1
|
YY1 associated protein 1
|
|
ZIC1
|
Zic family member 1
|
|
ZIC4
|
Zic family member 4
|
